FDA Class II Recall: Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product… by Fresenius Medical Care Renal Therapies Group, LLC

Key facts

What this classification means

A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate Hemodialysis should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Fresenius Medical Care Renal Therapies Group, LLC. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Fresenius Medical Care Renal Therapies Group, LLC should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Fresenius Medical Care Renal Therapies Group, LLC directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

Fresenius Medical Care Renal Therapies Group, LLC’s FDA history

Argus HQ has recorded 8 total FDA actions tied to Fresenius Medical Care Renal Therapies Group, LLC: 0 warning letters, 8 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

What is the FDA recall number for this event?

FDA recall number Z-3093-2026.

What is the current status of this recall?

Status as recorded by FDA: Ongoing.

Where can I verify this recall directly with FDA?

The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

Is Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialy recalled?

Yes. FDA lists a Class II recall by Fresenius Medical Care Renal Therapies Group, LLC for Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate Hemodialysis, reported 20260909, with status "Ongoing." FDA recall number: Z-3093-2026.

Related enforcement actions

• Recall: Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: 5008X HD/HDF Standard Blood Tubing Set Part Number 03-5300-3 →
• Recall: Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: 5008X HD/HDF with CLiC Blood Tubing Set Part number 03-5300-3C →
• Recall: Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: 5008X HD/HDF with Twister Blood Tubing Set Part Number 03-5350-8 →
• Recall: Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: NaturaLyte, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbe… →
• Recall: Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: GRANUFLO Dry Acid Concentrate: Product Numbers: 0FD2251-3B; 0FD3251-3B; Dry Ac… →
• Recall: Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: 5008X Standard HD Pre-Flush Standard Blood Tubing Set Part Number 03-5110-… →
• Recall: Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: Fresenius Medical Care, 2008T BlueStar Hemodialysis Machine, Model Numbers: 191… →